Please use this identifier to cite or link to this item:
http://localhost:8080/xmlui/handle/20.500.12421/517
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Vera, Omaira | - |
dc.contributor.author | de Brito, Paula Brelas | - |
dc.contributor.author | Albrecht, Letusa | - |
dc.contributor.author | Martins-Campos, Keillen Monick | - |
dc.contributor.author | P. Pimenta, Paulo F. | - |
dc.contributor.author | Monteiro, Wuelton M. | - |
dc.contributor.author | G. Lacerda, Marcus V. | - |
dc.contributor.author | P. Lopes, Stefanie C. | - |
dc.contributor.author | M. Costa, Fabio T. | - |
dc.date.accessioned | 2019-08-08T05:54:32Z | - |
dc.date.available | 2019-08-08T05:54:32Z | - |
dc.date.issued | 2015 | - |
dc.identifier.issn | 1098-6596 | - |
dc.identifier.uri | https://repository.usc.edu.co:8443/xmlui/handle/123456789/517 | - |
dc.description.abstract | Significant progress toward the control of malaria has been achieved, especially regarding Plasmodium falciparum infections. However, the unique biology of Plasmodium vivax hampers current control strategies. The early appearance of P. vivax gametocytes in the peripheral blood and the impossibility of culturing this parasite are major drawbacks. Using blood samples from 40 P. vivax-infected patients, we describe here a methodology to purify viable gametocytes and further infect anophelines. This method opens new avenues to validate transmission-blocking strategies. | en_US |
dc.language.iso | es | en_US |
dc.publisher | Antimicrobial Agents and Chemotherapy | en_US |
dc.title | Purification Methodology for Viable and Infective Plasmodium vivax Gametocytes That Is Compatible with Transmission-Blocking Assays. | en_US |
dc.type | Article | en_US |
Appears in Collections: | Producción Científica |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Purification Methodology for Viable and Infective Plasmodium vivax.pdf | 983.67 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.